会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • ACID ADDITION SALT OF CARBASUGAR AMINE DERIVATIVE
    • SÄUREADDITIONSSALZEINES CARBAZUCKERAMINDERIVATS
    • EP1632476A4
    • 2007-05-16
    • EP04745313
    • 2004-05-19
    • SEIKAGAKU KOGYO CO LTD
    • SUZUKI KIYOSHIIIDA MASAMIKANEDA YUJIKUNII NAOKOSAWA MIWA
    • C07C215/44A61K31/133A61K31/155A61P3/06A61P3/10C07C213/08C07C249/02C07C251/04C07C277/08C07C279/16
    • C07C215/44
    • An acid addition salt of a carbasugar amine derivative represented by the following general formula (1): wherein R and R each independently represents hydrogen or an alkyl, alkenyl, alkynyl, acyl, aryl, or aralkyl group optionally having one or more substituents represented by the following (I) or (II), or R and R in combination represent a substituent represented by the following (III): (wherein R to R each independently represents alkyl, alkenyl, alkynyl, acyl, aryl, or aralkyl), provided that not both of R and R are hydrogen; R , R , and R each independently represents hydroxy or substituted hydroxy; and R and R each independently represents hydrogen, hydroxy, or substituted hydroxy, provided that when one of R and R is hydrogen, then the other is hydroxy or substituted hydroxy.
    • 由下述通式(1)表示的卡巴糖胺衍生物的酸加成盐:其中R 1和R 2各自独立地表示氢或任选地具有取代基的烷基,烯基,炔基,酰基,芳基或芳烷基 (I)或(II)表示的一个或多个取代基,或者R 1和R 2一起表示由以下(III)表示的取代基:(其中R 8至R 12表示) 各自独立地表示烷基,烯基,炔基,酰基,芳基或芳烷基),条件是不是R 1和R 2都是氢; R 3,R 4和R 7各自独立地表示羟基或取代的羟基; 并且R 5和R 6各自独立地表示氢,羟基或取代的羟基,条件是当R 5和R 6中的一个是氢时,则另一个是羟基或取代的羟基。
    • 9. 发明公开
    • Fluorinated beta-ketoiminato metal complexes
    • 氟化β-酮基亚氨基 - 金属络合物。
    • EP0446772A1
    • 1991-09-18
    • EP91103405.6
    • 1991-03-06
    • AIR PRODUCTS AND CHEMICALS, INC.
    • Norman, John Anthony Thomas
    • C07C251/04
    • C07C251/06C23C16/18
    • Fluorinated β-ketoimine ligands and highly volatile β-ketoiminato metal complexes of the ligands are synthesized by silylating a fluorinated β-diketone to form a silylenolether, and subsequently reacting the silylenolether with a primary diamine to form the desired ligand having the structural formula:

      wherein R₁, R₂, R₄ and R₅ are independently linear or branched perfluorinated, C₁-C₈ alkyl groups and R₃ is any organic functionality such as a C₁-C₈ alkylene, phenylene or hydroxyalkylene group, all of which can be partially or fully fluorinated. The corresponding metal complex is formed by treating the ligand with a metal halide.
    • 配位体的氟化β-酮亚胺配体和高度挥发性的β-酮亚胺金属络合物是通过使氟化的β-二酮甲硅烷基化以形成甲硅烷基醚来合成的,随后使甲硅烷基醚与伯二胺反应形成具有以下结构式的所需配体: CHEM>其中R 1,R 2,R 4和R 5独立地是直链或支链全氟化的,C 1 -C 8烷基和R 3是任何有机官能团,例如C 1 -C 8亚烷基,亚苯基或羟基亚烷基,它们都可部分或完全氟化 。 通过用金属卤化物处理配体形成相应的金属络合物。